About
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.
We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.
2018 Agenda
8:00 AM: ARRIVAL
Registration, Breakfast, Networking
8:45 AM: WELCOMING REMARKS
9:15 AM: STRENGTHENING THE UNIVERSITY-CORPORATE CONNECTION – BIOTECH AND BEYOND: A Conversation with University Presidents
MODERATOR:
Brian K. Fitzgerald, EdD, CEO, Business-Higher Education Forum
SPEAKERS:
Ángel Cabrera, President, George Mason University
Dr. Wallace D. Loh, President, University of Maryland, College Park
Jay A. Perman, MD, President, University of Maryland, Baltimore
10:15 AM: UNIVERSITIES: FROM RESEARCH TO COMMERCIALIZATION
Geoffrey Lynn, CEO, Avidea Technologies
11:00 AM: NETWORKING BREAK
11:30 AM: BIOHEALTH REGIONAL STRENGTHS: IMMUNE-ONCOLOGY, CELL THERAPY & VACCINES
MODERATOR:
John Mumm, PhD, Director, Immunoncology R&D, MedImmune
PANELISTS:
Bill Hearl, CEO, Immunomic Therapeutics, Inc.
Matthew Mulvey, PhD, Founder & CEO, Benevir
Jeffrey Ulmer, PhD, Head, Preclinical R&D, GSK Vaccines
11:30 AM: EMERGING REGIONAL CLUSTERS: DIGITAL HEALTH, DEVICES AND AUGMENTED REALITY
MODERATOR:
William E. Bentley, Robert E. Fischell Distinguished Chair & Inaugural Director of the Robert E. Fischell Institute for Biomedical Devices
PANELISTS:
Dan Gura, PharmD, MPH, Director, Business Development, AlgometRx Inc.
Praduman Jain, BS, MS, Founder & CEO, PI AllofUs Research Program, NIH
Dr. Subha Madhavan, Chief Innovation Officer, Perthera
Dr. Amitabh Varshney, Dean of the College of Computer, Mathematical and Natural Sciences, University of Maryland
12:30 PM: LUNCH
1:30 PM: ANGEL INVESTORS: WHERE ARE THEY? WHAT DO THEY WANT? HOW DO I ACCESS THEM?
INTRODUCTION BY:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune
MODERATOR:
Jonathan Aberman, Managing Director, Amplifier Ventures
PANELISTS:
Jeff Galvin, CEO & Founder, American Gene Technologies International Inc.
Merom Klein, Principal, Courage Growth Partners
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Dendy Young, Managing Partner, McLean Capital LLC
2:30 PM: INVESTORS WITH A LOCAL PRESENCE
MODERATOR:
Andy Jones, Chief Investment Officer, TEDCO
PANELISTS:
Mike Thomas, Director, Inova Personalized Health Accelerator (IPHA)
Chris Otey, Senior Vice President, Science and Technology, Alexandria Real Estate Equities, Inc.
Cherine Eldumiati Plumaker, Managing Director, Pansend Life Sciences, LLC
David A. Present, MD, President & Senior Managing Director, Panned Life Sciences, LLC
R. Jacob Vogelstein, Partner & Portfolio Manager, Camden Partners Holdings, LLC
3:30 PM: NETWORKING BREAK
4:00 PM: Measurements, Standards, and Innovation for Better Health Care
INTRODUCTION:
Gail Wasserman, PhD, Senior Vice President, Biopharmaceutical Development, MedImmune
KEYNOTE:
Dr. Walter G. Copan, Under Secretary of Commerce for Standards and Technology and Director, NIST
4:20 PM: DAY ONE CLOSING REMARKS
KEYNOTE:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune
4:30 PM: GENERAL RECEPTION
8:00 AM: ARRIVAL
Registration, Breakfast, Networking
8:30 AM: CREATING COMPANIES FROM AN OPEN SCIENCE ECOSYSTEM
KEYNOTE:
Aled Edwards, PhD, Chief Executive, Structural Genomics Consortium (SGC), University of Toronto
9:00 AM: CRAB TRAP
MODERATOR:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
JUDGES:
Shaun Grady, Vice President, Business Development Operations, AstraZeneca
Sara Nayeem, MD, Partner, New Enterprise Associates
John Rubin, JP Morgan
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Robert Silverman, Head, Externalized Drug Discovery Partnering, Roche
Steven Zachary, Associate, Sands Capital Ventures
10:10 AM: BHCR Spotlight
SPEAKER:
James C. Powers, Chairman & CEO, HemoShear Therapeutics
Michael L. Salgaller, PhD, Supervisor, Invention Development and Marketing Unit, National Cancer Institute, National Institutes of Health
10:20 AM: NETWORKING BREAK
10:45 AM: TALES OF CEOs
MODERATOR:
Barbara Lopez Kunz, MS, Global Chief Executive, DIA
PANELISTS:
Angela Graham, President & CEO, Quality Biological, Inc.
David M. Hilbert, PhD, President & CEO, Arcellx, Inc.
Rachel K. King, Chief Executive Officer, GlycoMimetics, Inc.
Anne S. Lindblad, PhD, President and CEO, The Emmes Corporation
10:45 AM: TALES OF CSOs
MODERATOR:
Steve Projan, PhD, FAAM, Senior Vice President & Head, iMED, Infectious Diseases and Vaccines, MedImmune
PANELISTS:
Olivier Danos, CSO, RegenX Bio
W. James Jackson, Senior Vice President & CSO, Emergent BioSolutions
Ashish Kulkarni, Executive Vice President & Chief Technology Officer, Avantor
Benjamin Solomon, MD, FACMG, Managing Director, GeneDx, Inc.
11:45 AM: LAUNCHING AN AUTOIMMUNE FOCUSED BIOTECH SPINOFF FROM MEDIMMUNE: VIELA BIO
INTRODUCTION:
Lily Qi, Assistant Chief Administrative Officer, Montgomery County Office of the County Executive
KEYNOTE:
Dr. Bing Yao, CEO, Viela Bio
12:05 PM: LUNCH
1:05 PM: PUBLIC SUPPORT FOR BIOHEALTH ENTREPRENEURS
MODERATOR:
Beth Meagher, Deloitte Consulting Principal, Deloitte
PANELISTS:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council
Jason Miller, CEO, Greater Washington Partnership
Bret Schreiber, Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce
2:00 PM: KEYNOTE FROM SECRETARY OF HEALTH & HUMAN SERVICES, ALEX M. AZAR II
KEYNOTE:
Alex M. Azar II, Secretary, U.S. Department of Health and Human Services
2:20 PM: USING PATIENT INPUT TO DRIVE AND IMPROVE BIOMEDICAL INNOVATION
MODERATOR:
Margaret Anderson, Managing Director, Deloitte Consulting LLP
PANELISTS:
Lisa M. Guay-Woodford, MD, Director, Center for Translational Science, Children’s National Health System
Vasum Peiris, MD, MPH, FAAP, FACC, FASE, Chief Medical Officer, Pediatrics and Special Population, U.S. Food & Drug Administration
Marshall Summar, MD, Director, Rare Disease Institute, Children’s National Medical Center
3:10 PM: ROLE OF HOSPITALS IN CATALYZING HEALTH INNOVATION
MODERATOR:
Tina Reed, Executive Healthcare & Hospitals Editor, FierceHealthcare
SPEAKERS:
Kurt Newman, MD, President & CEO, Children’s National Health System
Todd A. Stottlemyer, CEO, Inova Center for Personalized Health
4:00 PM: CLOSING REMARKS
KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
2018 Speakers
Eduardo Davila, PhD
Associate Professor, Program Leader Tumor Immunology and Immunotherapy, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
Lisa M. Guay-Woodford, MD
Director, Center for Translational Science, Children's National Health System
Joel S. Marcus
Chairman, Chief Executive Officer and Founder, Alexandria Real Estate Equities Inc., and Alexandria Venture Investments
Vasum Peiris, MD, MPH, FAAP, FAAC, FASE
Chief Medical Officer, Pediatrics and Special Populations, U.S. Food & Drug Administration
Steve Projan, PhD, FAAM
Senior Vice President & Head, iMED, Infectious Diseases & Vaccines, MedImmune
Michael L. Salgaller, PhD
Supervisor, Invention Development & Marketing Unit, National Cancer Institute, National Institutes of Health
Bret Schreiber
Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce
Dr. Amitabh Varshney
Dean of the College of Computer, Mathematical, and Natural Sciences, University of Maryland
Crab Trap
2018 BHCR Crab Trap
You thought the Shark Tank was tough…
wait until you enter the the BioHealth Capital Region Crab Trap!
Finalists for the 3rd Annual Crab Trap Competition have been announced!
AlgometRx (Washington, DC) – developer of a digital medical device precision dosing tool which objectively measures the type and intensity of pain in real time, and also determines drug effect to personalize interventions used for pain management in both adult and pediatric patient populations.
Cellth Systems (Baltimore, MD) – developer of proprietary personalized medicine cell-tethering technology which identifies the ideal treatment drug(s) for oncologists and cancer patients.
Galen Robotics (Baltimore, MD) – developer of a low-cost, compact, and intuitive to use novel microsurgical robotic platform designed to assist surgeons with minimally-invasive applications in otolaryngology, neurosurgery and similar critical fields.
Renalert (Baltimore, MD) – developer of a low-cost, compact, and intuitive to use microsurgical robotic platform designed to prevent needless deaths due to AKI.
ReveraGen BioPharma – developer of vamorolone which targets the benefits of corticosteroids while dramatically reducing untoward side effects (i.e. bone fragility, stunting of growth, mood disorders, cataracts, and problems with glucose homeostasis). Reveragen has completed Phase 1 and First-in-Patient studies in boys with Duchenne and has requested Breakthrough Therapy Designation from the FDA.
Sponsored by:
Present at the BioHealth Capital Region Forum on April 24, 2018
Five finalists will have a chance to win the grand prize by presenting in
front of a panel of prominent industry funding experts and executives including:
- Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.
- Shaun Grady, VP, Strategic Partnering & Business Development, AstraZeneca
- Bethany Mancilla, VP, Business Development, Amgen
- Sara Nayeem, Partner, New Enterprise Associates (NEA)
- John T. Rubin, CFA, Executive Director, J.P. Morgan
- Dr. Paul Silber, Founding Principal, Blu Venture Investors
- Robert Silverman, Head Externalized Drug Discovery Partnering, Roche
- Stephen Zachary, Associate, Sands Capital Ventures
Grand Prize
$10,000
Incubation Space in Montgomery County, MD or Prince William County, VA
Business Mentoring
CRITERIA
Product
Technical Feasibility
Marketing/Strategy
Leadership Team
Financial/Projection
Register
- This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.
We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.